(CYP2C19[TI]) AND ((Genes[MH]) OR (Genetic Phenomena[MH])) AND english[la] AND human[mh] AND "last 720 days"[dp] - Search Results

Year	Number of Results
2022	2
2023	2
2024	57
2025	62
2026	17

1

Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis.

Li D, Pain O, Fabbri C, Wong WLE, Lo CWH, Ripke S, Cattaneo A, Souery D, Dernovsek MZ, Henigsberg N, Hauser J, Lewis G, Mors O, Perroud N, Rietschel M, Uher R, Maier W, Baune BT, Biernacka JM, Bondolfi G, Domschke K, Kato M, Liu YL, Serretti A, Tsai SJ, Weinshilboum R; GSRD Consortium, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium; McIntosh AM, Lewis CM. Li D, et al. Transl Psychiatry. 2024 Jul 19;14(1):296. doi: 10.1038/s41398-024-02981-1. Transl Psychiatry. 2024. PMID: 39025838 Free PMC article.

2

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole.

Klomp SD, Veringa A, Alffenaar JC, de Boer MGJ, Span LFR, Guchelaar HJ, Swen JJ. Klomp SD, et al. Clin Transl Sci. 2024 Jul;17(7):e13887. doi: 10.1111/cts.13887. Clin Transl Sci. 2024. PMID: 39010708 Free PMC article.

3

Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis.

Maas DPMSM, Willems LH, Kranendonk J, Kramers C, Warlé MC. Maas DPMSM, et al. Drugs. 2024 Oct;84(10):1275-1297. doi: 10.1007/s40265-024-02076-7. Epub 2024 Sep 5. Drugs. 2024. PMID: 39235670 Free PMC article.

4

Impact of CYP2C19 Genotype on Sertraline and Escitalopram Exposure and Antidepressant Switching Rate: A Retrospective Cohort Study of Chinese Han Patients.

Yan Y, Wang J, Wang D, Luan Y, Sun Q, Chen C, Lun Y, Zhao M, Su S, Yu J, Duan L, Zhao Y, Zhou C. Yan Y, et al. Clin Pharmacol Ther. 2025 Sep;118(3):632-641. doi: 10.1002/cpt.3707. Epub 2025 May 10. Clin Pharmacol Ther. 2025. PMID: 40346857

5

CYP2C19 Phenotype, P2Y(12) Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy.

Patel RC, Thomas CD, Rossi JS, Franchi F, Keeley EC, Beitelshees AL, Duarte JD, Ortega-Paz L, Kulick N, Winget M, Nguyen AB, Yang WE, Venkatesh S, Angiolillo DJ, Cavallari LH, Lee CR, Stouffer GA. Patel RC, et al. J Am Heart Assoc. 2025 Jul 15;14(14):e041634. doi: 10.1161/JAHA.125.041634. Epub 2025 Jul 3. J Am Heart Assoc. 2025. PMID: 40611487 Free PMC article.

6

CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis.

Pintaningrum Y, Vitriyaturrida, Dewi IP, Putra HBP, Mappangara I, Amir M, Yusuf I, Bukhari A. Pintaningrum Y, et al. F1000Res. 2025 Jan 15;11:346. doi: 10.12688/f1000research.109321.3. eCollection 2022. F1000Res. 2025. PMID: 38721014 Free PMC article.

7

Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy.

Wu Y, Zhou Y, Pan Y, Jin A, Meng X, Li H, Wang Y, Jiang Y, Wang Y. Wu Y, et al. Ren Fail. 2025 Dec;47(1):2526684. doi: 10.1080/0886022X.2025.2526684. Epub 2025 Jul 23. Ren Fail. 2025. PMID: 40701985 Free PMC article. Clinical Trial.

8

Evaluating the Evidence for CYP2C19 Inhibitor Classifications: A Scoping Review.

Malavé JG, Lopez A, Doan T, Cicali EJ, Desta Z, McDonough CW, Cavallari LH. Malavé JG, et al. Clin Pharmacol Ther. 2025 Nov;118(5):1100-1109. doi: 10.1002/cpt.3712. Epub 2025 May 20. Clin Pharmacol Ther. 2025. PMID: 40391533

9

Functional assessment of CYP3A4 and CYP2C19 genetic polymorphisms on the metabolism of clothianidin invitro.

Hu Y, Ye Z, Wu H, Chen X, Xia H, Cai JP, Hu GX, Xu RA. Hu Y, et al. Chem Biol Interact. 2024 Aug 25;399:111154. doi: 10.1016/j.cbi.2024.111154. Epub 2024 Jul 16. Chem Biol Interact. 2024. PMID: 39025286

10

Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis.

Galli M, Occhipinti G, Benenati S, Laborante R, Ortega-Paz L, Franchi F, D'Amario D, Nerla R, Castriota F, Frati G, Biondi-Zoccai G, Sciarretta S, Angiolillo DJ. Galli M, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):526-536. doi: 10.1093/ehjcvp/pvae036. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38754988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year